Your browser is no longer supported. Please, upgrade your browser.
Settings
PCRX Pacira Pharmaceuticals, Inc. daily Stock Chart
PCRX [NASD]
Pacira Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.31 Insider Own0.40% Shs Outstand48.58M Perf Week-14.90%
Market Cap1.48B Forward P/E60.74 EPS next Y0.50 Insider Trans-33.75% Shs Float40.37M Perf Month-22.36%
Income-51.20M PEG- EPS next Q0.10 Inst Own- Short Float8.03% Perf Quarter-24.10%
Sales280.50M P/S5.29 EPS this Y-114.50% Inst Trans-3.33% Short Ratio3.63 Perf Half Y-14.55%
Book/sh6.54 P/B4.67 EPS next Y744.40% ROA-9.30% Target Price47.83 Perf Year-30.80%
Cash/sh6.05 P/C5.05 EPS next 5Y35.15% ROE-20.20% 52W Range29.35 - 58.95 Perf YTD-33.08%
Dividend- P/FCF- EPS past 5Y16.50% ROI-9.80% 52W High-48.18% Beta1.82
Dividend %- Quick Ratio6.20 Sales past 5Y77.50% Gross Margin67.80% 52W Low4.09% ATR2.30
Employees503 Current Ratio7.00 Sales Q/Q-1.60% Oper. Margin-14.10% RSI (14)30.58 Volatility6.27% 6.08%
OptionableYes Debt/Eq1.03 EPS Q/Q68.40% Profit Margin-18.20% Rel Volume0.95 Prev Close30.15
ShortableYes LT Debt/Eq1.03 EarningsFeb 28 BMO Payout- Avg Volume893.05K Price30.55
Recom2.40 SMA20-16.43% SMA50-24.64% SMA200-25.54% Volume844,919 Change1.33%
Feb-16-18Downgrade Needham Buy → Hold
Jan-19-18Initiated Seaport Global Securities Buy $50
Jan-04-18Reiterated Canaccord Genuity Buy $42 → $46
Jan-03-18Initiated Leerink Partners Mkt Perform $46
Dec-18-17Initiated JP Morgan Neutral $47
Nov-29-17Downgrade Mizuho Buy → Neutral $53 → $44
Nov-09-17Resumed H.C. Wainwright Buy $52
Oct-26-17Downgrade Janney Neutral → Sell
Oct-19-17Reiterated Needham Buy $55 → $52
Sep-28-17Initiated Goldman Neutral $41
Sep-07-17Initiated Oppenheimer Perform
Aug-22-17Initiated Needham Buy $55
Aug-21-17Upgrade Janney Sell → Neutral
May-05-17Reiterated Mizuho Buy $57 → $54
Apr-13-17Initiated RBC Capital Mkts Outperform $58
Mar-23-17Reiterated Mizuho Buy $59 → $54
Mar-21-17Reiterated Barclays Overweight $54 → $59
Mar-02-17Reiterated H.C. Wainwright Buy $48 → $59
Feb-22-17Initiated Canaccord Genuity Buy $55
Jan-03-17Initiated H.C. Wainwright Buy $43
Feb-22-18 04:00PM  Pacira Pharmaceuticals Announces Timing for 2017 Financial Results Webcast and Conference Call GlobeNewswire
Feb-20-18 10:41AM  Heres Whats Moving Apricus Biosciences And Pacira Pharmaceuticals Market Exclusive
Feb-16-18 04:15PM  This Biotech Stock May Need Anesthesia After Collapsing Nearly 20% Investor's Business Daily -16.48%
07:30AM  Pacira Pharmaceuticals to Present at the 2018 RBC Capital Markets Healthcare Conference GlobeNewswire
Feb-15-18 05:26PM  FDA Panel Votes 6-4 Against Recommending This Biotech's Pain Blocker Investor's Business Daily
03:34PM  Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia GlobeNewswire
08:15AM  Consolidated Research: 2018 Summary Expectations for Pacira Pharmaceuticals, Wabash National, Spirit Airlines, Praxair, Altice, and Gap Fundamental Analysis, Key Performance Indications GlobeNewswire
Feb-14-18 04:39PM  What You Must Know About Pacira Pharmaceuticals Incs (NASDAQ:PCRX) Financial Strength Simply Wall St.
01:28PM  Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia GlobeNewswire
Feb-12-18 01:29PM  FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia GlobeNewswire
Feb-09-18 08:50AM  Implied Volatility Surging for Pacira (PCRX) Stock Options Zacks
Jan-09-18 08:05AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Jan-08-18 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
07:30AM  WellStar Health System and Pacira Pharmaceuticals Announce Partnership to Minimize Opioid Use and Standardize Outcomes Across Surgical Procedures GlobeNewswire
Jan-05-18 08:02AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Jan-04-18 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit -7.44%
07:30AM  Pacira Pharmaceuticals Reports Preliminary 2017 Revenues of $286.6 Million GlobeNewswire
Jan-03-18 07:30AM  Pacira Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-02-18 08:05AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Dec-28-17 08:02AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Dec-27-17 03:00AM  IBD Rating Upgrades: Pacira Pharmaceuticals Shows Improved Relative Price Strength Investor's Business Daily
Dec-26-17 11:58AM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : December 26, 2017 Capital Cube
Dec-25-17 09:30AM  Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017 Capital Cube
Dec-14-17 07:30AM  Illinois Surgical Quality Improvement Collaborative and Pacira Pharmaceuticals, Inc. Announce Collaboration to Minimize Opioid Exposure for Postsurgical Patients GlobeNewswire
Dec-13-17 03:00AM  Stocks Showing Improving Market Leadership: Pacira Pharmaceuticals Earns 81 RS Rating Investor's Business Daily
Dec-11-17 02:45AM  Pacira (PCRX) Up 9.3% Since Earnings Report: Can It Continue? Zacks
Dec-08-17 07:30AM  Pacira Pharmaceuticals to Present at the 2017 BMO Capital Markets Prescriptions for Success Healthcare Conference GlobeNewswire
03:00AM  Pacira Pharmaceuticals Sees RS Rating Climb To 75 Investor's Business Daily
Dec-07-17 07:38AM  Pacira Pharmaceuticals names Scott Braunstein COO, Richard Scranton as chief scientific officer MarketWatch
07:30AM  Pacira Announces Promotions of Scott Braunstein, MD, to Chief Operating Officer and Richard Scranton, MD, to Chief Scientific Officer GlobeNewswire
Dec-01-17 08:10AM  Recent Analysis Shows Praxair, Rockwell Automation, Gap, Pacira Pharmaceuticals, Wabash National, and Spirit Airlines Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-29-17 07:00AM  Cancer Treatment Centers of America® Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opioid Use PR Newswire
03:00AM  Stocks Flashing Renewed Technical Strength: Pacira Pharmaceuticals Investor's Business Daily
Nov-27-17 08:05AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Nov-22-17 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Nov-20-17 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Nov-17-17 08:05AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Nov-16-17 07:13AM  Pharma Stock Roundup: FDA Nod for AstraZeneca Severe Asthma Drug, Bayer Signs Deal with Loxo Zacks
Nov-15-17 10:19AM  Pacira's Exparel sNDA to be Reviewed by FDA Advisory Committee Zacks
Nov-14-17 04:21PM  This Biotech Is Feeling The Pain After FDA Sets Panel On Anesthetic Investor's Business Daily -6.61%
07:30AM  Pacira Announces FDA Advisory Committee Meeting to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia GlobeNewswire
Nov-12-17 12:41AM  Edited Transcript of PCRX earnings conference call or presentation 8-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
Nov-09-17 05:00PM  Pacira Pharmaceuticals to Present at Two November Healthcare Conferences GlobeNewswire
Nov-08-17 04:13PM  The Bottom Line on Why Pacira Pharmaceuticals Inc. Rocketed Higher by as Much as 24% Motley Fool +16.98%
07:39AM  Pacira reports 3Q loss Associated Press
07:30AM  Pacira Pharmaceuticals, Inc. Reports Third Quarter 2017 Financial Results Marketwired
Nov-07-17 11:18AM  Pacira Pharmaceuticals, Inc. Value Analysis (NASDAQ:PCRX) : November 7, 2017 Capital Cube
Nov-06-17 12:17PM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : November 6, 2017 Capital Cube
07:17AM  Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PCRX-US : November 6, 2017 Capital Cube
Nov-01-17 08:02AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-31-17 07:30AM  Pacira Pharmaceuticals Announces Timing for Third Quarter 2017 Financial Results Webcast and Conference Call GlobeNewswire
Oct-27-17 08:02AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-25-17 08:00AM  Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement GlobeNewswire
Oct-24-17 09:41AM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : October 24, 2017 Capital Cube
Oct-20-17 07:20AM  Featured Company News - Pacira Announces FDA Acceptance of sNDA for EXPAREL ACCESSWIRE
Oct-19-17 08:04AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-18-17 07:30AM  Pacira Pharmaceuticals Announces FDA Acceptance of sNDA for EXPAREL as a Nerve Block to Produce Regional Analgesia GlobeNewswire
Oct-16-17 09:42AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-13-17 11:08AM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : October 13, 2017 Capital Cube
Oct-06-17 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Oct-02-17 11:01AM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : October 2, 2017 Capital Cube
Sep-29-17 09:05AM  Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
08:07AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Sep-28-17 08:17AM  Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PCRX-US : September 28, 2017 Capital Cube
Sep-27-17 07:30AM  Pacira Pharmaceuticals CEO to Testify at White House Opioid Crisis Commission Meeting GlobeNewswire
Sep-26-17 08:00AM  New Research: Overprescribing of Postsurgical Opioids Poses a Serious Threat to Patients and their Communities; Women Undergoing Surgery are at Greatest Risk GlobeNewswire
Sep-25-17 08:07AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Sep-20-17 07:30AM  Pacira Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-19-17 08:02AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Sep-13-17 07:30AM  Pacira Pharmaceuticals, Aetna, and the American Association of Oral and Maxillofacial Surgeons Join Together in a Program to Reduce Opioid Exposure for Patients Undergoing Wisdom Tooth Extraction GlobeNewswire
Sep-12-17 08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Sep-11-17 10:08AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Sep-07-17 08:01AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Sep-06-17 07:30AM  Pacira Pharmaceuticals Announces Multiple EXPAREL Data Presentations at the Upcoming New York School of Regional Anesthesia Annual Fall Symposium GlobeNewswire
Sep-05-17 07:30AM  Pacira Pharmaceuticals to Present at the 2017 H.C. Wainwright 19th Annual Global Investment Conference GlobeNewswire
Aug-31-17 07:30AM  Pacira Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference GlobeNewswire
Aug-24-17 06:21PM  Steven Cohen Plunges Into Opioid Replacement Maker Pacira GuruFocus.com
Aug-14-17 09:20AM  Pacira Pharmaceuticals Focuses on Exparel's Label Expansion Zacks
08:03AM  See what the IHS Markit Score report has to say about Pacira Pharmaceuticals Inc. Markit
Aug-13-17 03:36AM  Edited Transcript of PCRX earnings conference call or presentation 2-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-10-17 06:31PM  [$$] Maverick Therapeutics Taps Former Pacira Executive as CEO The Wall Street Journal
Aug-09-17 07:30AM  Pacira Pharmaceuticals to Present at the 2017 Wedbush Pacgrow Healthcare Conference GlobeNewswire
Aug-07-17 06:31PM  Pacira Pharmaceuticals, Inc. Value Analysis (NASDAQ:PCRX) : August 7, 2017 Capital Cube
Aug-03-17 08:18AM  Pacira (PCRX) Q2 Loss Wider than Expected, Revenues Miss Zacks
Aug-02-17 10:51PM  Pacira reports 2Q loss Associated Press
07:30AM  Pacira Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial Results GlobeNewswire
06:30AM  Investor Network: Pacira Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Jul-27-17 02:26PM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : July 27, 2017 Capital Cube
Jul-26-17 02:34PM  Pacira Pharmaceuticals Inc (PCRX) and EXACT Sciences Corporation (EXAS) Are Shaking Up the Market SmarterAnalyst
09:35AM  Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PCRX-US : July 26, 2017 Capital Cube
07:30AM  Pacira Announces Publication of Phase 4 Study of EXPAREL in Patients Undergoing Total Knee Replacement in The Journal of Arthroplasty GlobeNewswire
Jul-25-17 05:00PM  Pacira Pharmaceuticals Announces Timing for Second Quarter 2017 Financial Results Webcast and Conference Call GlobeNewswire -12.42%
12:39PM  Why Pacira Pharmaceuticals Shares Are Crashing 15% Today Motley Fool
07:30AM  Pacira Announces Topline Phase 3 Results for EXPAREL® as a Single-dose Nerve Block GlobeNewswire
Jul-17-17 01:50PM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : July 17, 2017 Capital Cube
Jul-06-17 02:06PM  ETFs with exposure to Pacira Pharmaceuticals, Inc. : July 6, 2017 Capital Cube
Jun-30-17 08:04AM  4 Small-Cap Stocks Set to Grow EPS by at Least 400% Through 2020 Motley Fool
Jun-22-17 08:13AM  Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PCRX-US : June 22, 2017 Capital Cube
Jun-15-17 07:30AM  Pacira Pharmaceuticals Appoints Mark I. Froimson, M.D., to Board of Directors GlobeNewswire
Jun-14-17 07:30AM  Pacira Pharmaceuticals to Present at the JMP Securities Life Sciences Conference GlobeNewswire
Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company's lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for infiltration into the surgical site to produce postsurgical analgesia. Its development pipeline comprises DepoTranexamic Acid, a long-acting local antifibrinolytic agent, which is in Phase II clinical development for the treatment or prevention of excessive blood loss during surgery by preventing the breakdown of a clot; and DepoMeloxicam, a long-acting non-steroidal anti-inflammatory drug, which is in preclinical development for the treatment of acute postsurgical pain. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STACK DAVID MCEO and ChairmanJan 10Option Exercise1.6128,88546,505129,331Jan 12 06:15 PM
STACK DAVID MCEO and ChairmanJan 10Sale40.1928,8851,160,975100,446Jan 12 06:15 PM
Riker Lauren BullaroVice President, FinanceDec 15Sale43.7034014,85810,442Dec 18 07:52 PM
Jones James BSVP & Chief Medical OfficerNov 20Sale41.1185034,94216,823Nov 20 06:43 PM
Williams Kristen MarieCAO and General CounselNov 17Option Exercise25.377,857199,33229,169Nov 20 06:44 PM
Williams Kristen MarieCAO and General CounselNov 17Sale40.007,857314,28021,312Nov 20 06:44 PM
Williams Kristen MarieCAO and General CounselNov 16Option Exercise25.372,14354,36823,455Nov 20 06:44 PM
Williams Kristen MarieCAO and General CounselNov 16Sale40.012,14385,74121,312Nov 20 06:44 PM
STACK DAVID MCEO and ChairmanNov 15Option Exercise1.6128,88546,505159,164Nov 17 05:15 PM
STACK DAVID MCEO and ChairmanNov 15Sale38.3458,8852,257,708100,279Nov 17 05:15 PM
Kronenfeld Mark A.DirectorNov 10Buy41.601,00041,6036,795Nov 13 08:03 PM
HASTINGS PAUL JDirectorAug 22Sale36.151,04437,7413,518Aug 24 08:30 PM
STACK DAVID MCEO and ChairmanAug 15Option Exercise1.6128,88546,505159,164Aug 17 06:55 PM
Williams Kristen MarieCAO and General CounselAug 15Sale36.753,461127,19221,312Aug 17 06:56 PM
STACK DAVID MCEO and ChairmanAug 15Sale36.3728,8851,050,547130,279Aug 17 06:55 PM
Froimson MarkDirectorAug 08Buy37.131003,713100Aug 16 08:43 PM
STACK DAVID MCEO and ChairmanJul 24Option Exercise1.6115,00024,150130,279Jul 26 05:28 PM
STACK DAVID MCEO and ChairmanJun 23Option Exercise1.6115,00024,150115,059Jun 27 08:22 PM
Riker Lauren BullaroVice President, FinanceJun 07Sale44.371,11949,6507,063Jun 09 07:08 PM
Williams Kristen MarieCAO and General CounselJun 05Sale43.321,87781,31413,773Jun 07 07:03 PM
STACK DAVID MCEO and ChairmanJun 05Sale43.324,311186,75759,559Jun 07 07:02 PM
Scibetta James SPresidentJun 05Sale43.321,96685,16925,118Jun 07 07:00 PM
Jones James BSVP & Chief Medical OfficerJun 05Sale43.3276733,2279,813Jun 07 06:58 PM
Riker Lauren BullaroVice President, FinanceJun 05Sale43.3260126,0368,182Jun 07 06:59 PM
Braunstein ScottSVP, Strategy & Corp. Dev.Jun 05Sale43.3276833,2719,982Jun 07 06:57 PM
Scibetta James SPresidentMay 15Option Exercise5.4920,000109,80047,084May 17 06:44 PM
Williams Kristen MarieCAO and General CounselMay 15Option Exercise10.5021,041220,85636,691May 17 06:45 PM
Scibetta James SPresidentMay 15Sale51.2020,0001,024,00027,084May 17 06:44 PM
Williams Kristen MarieCAO and General CounselMay 15Sale50.8621,0411,070,14515,650May 17 06:45 PM